scholarly journals Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response

Allergy ◽  
2019 ◽  
Vol 74 (8) ◽  
pp. 1579-1581 ◽  
Author(s):  
Claudia Kitzmüller ◽  
Beatrice Jahn‐Schmid ◽  
Tamar Kinaciyan ◽  
Barbara Bohle
Keyword(s):  
Sublingual Immunotherapy ◽  
Th2 Response ◽  
Mal D 1

Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy

2018 ◽  
Vol 141 (3) ◽  
pp. 1002-1008 ◽  
Author(s):  
Tamar Kinaciyan ◽  
Birgit Nagl ◽  
Sandra Faustmann ◽  
Florian Frommlet ◽  
Stephan Kopp ◽  
...  
Keyword(s):  
Sublingual Immunotherapy ◽  
Birch Pollen ◽  
Efficacy And Safety ◽  
Bet V 1 ◽  
Mal D 1

Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1

2007 ◽  
Vol 119 (4) ◽  
pp. 937-943 ◽  
Author(s):  
Tamar Kinaciyan ◽  
Beatrice Jahn-Schmid ◽  
Astrid Radakovics ◽  
Bettina Zwölfer ◽  
Claudia Schreiber ◽  
...  
Keyword(s):  
Immune Response ◽  
Food Allergy ◽  
Sublingual Immunotherapy ◽  
Birch Pollen ◽  
Bet V 1 ◽  
Mal D 1
Sign in / Sign up

Export Citation Format

Share Document